Where One Lives Impacts Dementia Risk
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 13, 2024 -- Neighborhood disadvantage is more strongly associated with measures of cardiometabolic health and cognition in individuals without mild cognitive impairment (MCI) compared to those with MCI, according to a study published online Dec. 6 in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.
Sudarshan Krishnamurthy, from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues investigated the relationship between neighborhood disadvantage with measures of cardiometabolic health and cognition. Analysis included 537 adults (aged >55 years) participating in the Wake Forest Alzheimer's Disease Research Center Healthy Brain Study (between 2016 and 2021); 39.3 percent had MCI.
The researchers found that Area Deprivation Index (ADI) was positively associated with blood pressure and cardiometabolic index (CMI). There was a negative association between ADI and global and Preclinical Alzheimer's Cognitive Composite scores in cognitively unimpaired individuals. In individuals with MCI, ADI was only positively associated with hemoglobin A1c.
"Neighborhood disadvantage is associated more strongly with measures of cardiometabolic health and cognition among cognitively unimpaired individuals rather than MCI," the authors write. "These findings demonstrate a need for structural solutions to address social determinants of health in an attempt to reduce cardiometabolic and cognitive risks."
One author disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-14 06:00
Read more
- A Number of Older Adults Report Loneliness, Social Isolation
- Increased Consumption of Dark Chocolate Linked to Lower Risk for T2DM
- Antibiotics or Surgery: What's Best for Child Appendicitis?
- Everything You Need to Know About Shingles & the Shingles Vaccine
- There's a 'Sweet Spot' for Daily Sugar Intake & Heart Health
- FDA Asks Biden Administration to Limit Nicotine in Tobacco Products
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions